SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community debates its next move, with some anticipating a pump while others express skepticism. Discussions also highlight a potential upgrade and BitMine's increasing ETH holdings, with community members weighing the impact of these factors on its value. Additionally, there is an ongoing discussion and warnings about a potential scammer in the community.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

SOL is trending due to reports of scams and pump and dumps, with some users warning others to be careful. Despite this, some community members remain bullish, suggesting that current prices are a good entry point and highlighting potential for a year-end rally. There is also discussion around new projects building on Solana, along with comparisons to other cryptocurrencies.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as users discuss the concept of earning crypto by being active. The community highlights the incentive to stay healthy and earn rewards through the Sweat Wallet app. Some users express long-term optimism, anticipating future growth and broader adoption of the token.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending amid discussions around its financials, potential stock manipulation, and recent news of allowing Bitcoin as loan collateral. The community is debating the implications of these developments, with some expressing concerns about the bank's practices and others highlighting its growth potential and AI initiatives. Some investors are also referencing technical analysis and potential trading strategies for JPM.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as retail traders express excitement around Alphabet's AI advancements, particularly the Gemini 3 model, with some touting it as an OpenAI killer. Bullish sentiment is further fueled by Berkshire Hathaway's recent investment, while the community debates whether GOOGL is now overbought or still undervalued relative to its peers in the AI space.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

$FARTCOIN is trending amid community discussions about its potential and volatility as a memecoin within the broader crypto market. Some traders are weighing its potential for explosive moves, while others express concerns about its stability and correlation with other speculative assets. The conversation also includes speculation around future price predictions, new partnerships, and comparisons to other memecoins.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending amid speculation of potential acquisitions, particularly within the MASH and obesity space, with Altimmune being a frequent mention. Community discussions revolve around Sanofi's pipeline expansion and strategic moves, with some suggesting connections to various biotech companies.  Concerns are also being raised regarding clinical trial data from Altimmune creating polarized viewpoints and board spamming.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

mF International ($MFI) is trending due to its recent $500M private placement to build a Bitcoin Cash ($BCH) treasury, fueling speculation about its potential as a crypto equity play. The community is buzzing about the involvement of Dawei Yuan, a Chinese crypto billionaire, and potential international aspirations beyond a Chinese version of MicroStrategy ($MSTR). Some traders caution against potential dilution, while others foresee a squeeze, drawing parallels to other high-flying stocks.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharma is trending amid buyout speculation and anticipation of EU approval for Rezdiffra, with community members discussing potential acquisition prices. Despite competition from GLP-1 drugs, some believe Madrigal's targeted approach and potential combination therapies position it for continued success in the MASH market. Bullish sentiment is fueled by insider buying and analysts predicting significant upside.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending amidst discussions of its pending merger with Infleqtion, a quantum computing company; the community is weighing the potential impact of the merger and recent partnerships. Some traders express confidence in Infleqtion's technology and long-term prospects, while others remain cautious, referencing the performance of other quantum stocks and SPACs.

statis crypto Watchlist

Bitcoin

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harvard Bioscience Sets Incentive Plan for Top Executives

Harvard Bioscience (HBIO) has provided an announcement. Harvard Bioscience, Inc.'s Compensation Committee has recently greenlit the 2024 annual cas...

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at...

Harvard Bioscience (HBIO, $4.4) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 8, 2024

This is a Bullish indicator signaling HBIO's price could rise from here. Traders may explore going long the stock or buying call options...

Q4 2023 Harvard Bioscience Inc Earnings Call Transcript

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript...

Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation

Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation...

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...

Panorama des b n fices de Harvard Bioscience

Harvard Bioscience (NASDAQ:HBIO) est cens e publier ses derniers b n fices ce jeudi. Voici l'opinion de Benzinga\ sur le rapport de r sultats quatri me trimestre de Harvard Bioscience.
R sultat net...

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analyticsHOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience...

Harvard Bioscience (HBIO, $4.89) price moved above its 50-day Moving Average on February 15, 2024

This price move could indicate a change in the trend, and may be a buy signal for investors...

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

HBIO
Harvard Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HBIO News

HBIOHarvard Bioscience Inc.